Stereotactic ablative radiotherapy for oligometastatic breast cancer: A systematic review and meta-analysis (SABRINA).
OBJECTIVE Stereotactic ablative radiotherapy (SABR) is increasingly used for oligometastatic breast cancer, but it is unclear in whom local ablation translates into systemic benefit. We compared de novo oligometastatic (OM) with oligoprogressive (OP) disease and synthesised randomised evidence. MATERIALS AND METHODS...